An antiviral drug called remdesivir is the first treatment to show efficacy against the coronavirus. Preliminary results from a clinical trial comparing the drug with a placebo suggest that ...
The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir should be made available for people seriously ill with COVID-19, despite limited data on its efficacy. The EMA’s human ...
Zydus Cadila, on August 13, launched the cheapest version of Remdesivir under the brand name Remdac. Apart from Cipla and Hetero Labs, Jubilant Lifesciences and Mylan are working to manufacture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback